BioHarvest Sciences Inc. Common Stock
NASDAQ:BHSTAgricultural Inputs
+$0.08 today
- Market cap
- $50.25M
- Beta
- 1.33
- P/E (TTM)
- -6.6
- EPS (TTM)
- -$0.50
Volume 0.01M
Average 0.03M
BHST Net Income
Bottom-line profit, the starting point for calculating cash from operations.
BioHarvest Sciences Inc. Common StockNASDAQ: BHST
Net Income · Q1 FY2026 · quarter ended Mar 2026
Net income grows, but more slowly than its trailing trend
Q1 FY2026 net income of $2.64M (cash outflow) rose 13.0% year over year, behind the +31.9% change in trailing-twelve-month net income. Sequentially, it rose 19.8% from the prior quarter. Over 3 fiscal years it compounded at -0.3% a year.
Context
- Net income amounted to 32.3% of revenue in FY2025, down 19.0 pp from a year earlier.
- Net income grew in size in 2 of the last 3 fiscal years.
- FY2025 was the smallest annual figure in the 4 fiscal years shown.
What to watch
Whether net income reaches the consensus estimate from 3 analysts of -$7.27M (-34.7%) for the fiscal year ending Dec 2026, a slowdown from the -13.8% reported in FY2025.
Sources:Cash Flow Analyst consensus estimates Text generated from reported figures; not investment advice.
- Latest quarterMar 2026
- -$2.64M+19.8% QoQ
- Last fiscal yearDec 2025
- -$11.14M-13.8% YoY
- LTMMar 2026
- -$11.44M+31.9% YoY
| Horizon | Past | Forecast | Difference |
|---|---|---|---|
| Quarter | +13.0% | -34.7% | -47.7 pp |
| 1 year | -13.8% | -34.7% | -20.9 pp |
| 3-year CAGR | -0.3% | — | — |
| 5-year CAGR | — | — | |
| 10-year CAGR | — | — |
Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.
Net Income history
USD · from the cash flow
- Latest · FY2025
- (11.14M) USD
- Year-over-year change
- +13.8%
| Period | Period end | Net Income | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | (11.14M) | +13.8% |
| FY2024 | 2024-12-31 | (12.91M) | -2.8% |
| FY2023 | 2023-12-31 | (12.56M) | -11.8% |
| FY2022 | 2022-12-31 | (11.24M) | -14.3% |
| FY2021 | 2021-12-31 | (9.83M) | — |
Net Income vs competitors
How BHST compares with its peers on the latest reported figures
- BHST's LTM Mar 2026 net income of $11.44M is the 6th largest of the 9 companies compared; the peer median is $9.75M.
- Its year-over-year change of +31.9% is the 5th highest of 8, against a peer median of +42.3%.
- Net income amounts to 32.5% of revenue for BHST, versus a peer median of 8.7%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Mar 2026 | $527.55M | +481.1% | — | 28.5% | |
| LTM Mar 2026 | $52.34M | +708.9% | — | 47.5% | |
| LTM Mar 2026 | $45.56M | -66.6% | — | 8.7% | |
| LTM Mar 2026 | $19.5M | +220.5% | -3.4% | 3.0% | |
USGOU.S. GoldMining Inc. | LTM Feb 2026 | $12.95M | — | — | — |
| LTM Mar 2026 | $11.44M | +31.9% | -0.3% | 32.5% | |
| LTM Mar 2026 | $9.62M | -18.0% | -36.8% | 3.5% | |
| LTM Mar 2026 | $6.56M | -20.2% | — | 8.6% | |
| LTM May 2025 | $4.59M | +42.3% | — | 8.7% | |
| Peer median (excluding BHST) | $9.75M | +42.3% | -20.1% | 8.7% | |
Competitors are the stored peer set for BHST. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Net Income | (9.83M) | (11.24M) | (12.56M) | (12.91M) | (11.14M) |
| Depreciation & Amortization | 385.58K | 712K | 840K | 1.25M | 1.62M |
| Deferred Income Tax | 0 | 0 | 0 | 0 | 0 |
| Stock-Based Compensation | 3.37M | 1.35M | 563K | 601K | 597K |
| Change in Working Capital | (96K) | (308K) | 755K | (555K) | (1.94M) |
| Accounts Receivables | (266K) | (588K) | (22K) | (594K) | (1.11M) |
| Inventory | (828K) | (450K) | (1.09M) | (1.19M) | (904K) |
| Accounts Payables | 0 | 730K | 0 | 1.04M | 0 |
| Other Working Capital | 998K | 0 | 1.87M | 188K | 67K |
| Other Non-Cash Items | (627K) | 239K | 1.88M | 4.93M | 3.63M |
| Operating Cash Flow | (6.79M) | (9.24M) | (8.52M) | (6.68M) | (7.23M) |
| Capital Expenditures | (1.64M) | (1.26M) | (1.47M) | (2.84M) | (2.36M) |
| Acquisitions (Net) | 0 | 0 | 0 | 0 | 0 |
| Purchases of Investments | 0 | 0 | 0 | 0 | 0 |
| Sales of Investments | 0 | 0 | 0 | 0 | 0 |
| Other Investing Activities | 0 | 0 | 0 | (192K) | (10K) |
| Investing Cash Flow | (1.64M) | (1.26M) | (1.47M) | (3.03M) | (2.37M) |
| Debt Repayment | (332K) | 7.3M | 13.15M | 2.04M | 5.25M |
| Common Stock Issued | 7.47M | 877K | 534.17K | 4.33M | 25.1M |
| Common Stock Repurchased | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | 3.64M | (38K) | (131.17K) | 408K | (159K) |
| Financing Cash Flow | 10.77M | 8.14M | 13.56M | 6.78M | 30.19M |
| Effect of Forex Changes | (4K) | (22K) | 59K | (34K) | 39K |
| Net Change in Cash | 2.33M | (2.38M) | 3.62M | (2.97M) | 20.64M |
| Free Cash Flow | (8.43M) | (10.5M) | (10M) | (9.52M) | (9.58M) |
BioHarvest Sciences Inc. Common Stock
NASDAQ:BHST
Intrinsic Alpha fair value
Locked
Current Price
$2.90
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.